Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention.
作者信息
Lombo Bernardo, Díez José G
出版信息
Future Cardiol. 2011 May;7(3):281-5. doi: 10.2217/fca.11.20.
PMID:21627469
Abstract
摘要
相似文献
1
Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention.介入心脏病学中的未来抗凝药物：经皮冠状动脉介入治疗中的抗IXa和抗Xa药物
Future Cardiol. 2011 May;7(3):281-5. doi: 10.2217/fca.11.20.
2
Otamixaban in acute coronary syndromes.奥扎米班用于急性冠状动脉综合征
Lancet. 2009 Sep 5;374(9692):762-4. doi: 10.1016/S0140-6736(09)61529-4. Epub 2009 Aug 28.
3
Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.经皮介入治疗中的当前抗凝选择：制定个性化策略。
Rev Cardiovasc Med. 2002 Fall;3(4):176-82.
4
New anticoagulant agents in acute coronary syndromes.急性冠状动脉综合征中的新型抗凝药物。
Heart. 2011 Feb;97(3):244-52. doi: 10.1136/hrt.2009.184333.
5
Anticoagulation during percutaneous coronary intervention in diabetics--is simpler always better?糖尿病患者经皮冠状动脉介入治疗期间的抗凝——越简单就总是越好吗？
J Invasive Cardiol. 2010 Mar;22(3):101-2.
6
Bivalirudin: role in current percutaneous coronary intervention practice.比伐卢定：在当前经皮冠状动脉介入治疗实践中的作用。
Br J Hosp Med (Lond). 2005 Dec;66(12):687-9. doi: 10.12968/hmed.2005.66.12.20208.
7
Antithrombotics for PCI: an indigenous direct thrombin inhibitor (DTI) makes the cut.用于经皮冠状动脉介入治疗的抗栓药物：一种本土直接凝血酶抑制剂（DTI）符合要求。
Indian Heart J. 2008 Jul-Aug;60(4):284-6.
8
Anticoagulant for primary percutaneous coronary intervention - the last dance for unfractionated heparin?用于直接经皮冠状动脉介入治疗的抗凝剂——普通肝素的最后一曲？
Arch Cardiovasc Dis. 2012 May;105(5):259-61. doi: 10.1016/j.acvd.2012.03.002. Epub 2012 May 22.
9
Bivalirudin for mechanical rotational atherectomy: the quest for better outcomes.比伐卢定用于机械性旋切术：追求更好的治疗效果。
J Interv Cardiol. 2010 Jun;23(3):230-2. doi: 10.1111/j.1540-8183.2010.00552.x.
10
Bivalirudin in acute coronary syndromes and percutaneous coronary intervention.比伐卢定在急性冠脉综合征及经皮冠状动脉介入治疗中的应用
Rev Cardiovasc Med. 2006;7 Suppl 3:S27-34.
Zotero 插件